Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Oct
3
2022
UPSTO Extends Pilot Programs Foley & Lardner LLP
Oct
3
2022
Attention New Jersey Employers: NJ Cannabis Regulatory Commission Issues Interim Guidance on Workplace Impairment Greenberg Traurig, LLP
Oct
3
2022
New FDA Guidance Allows Companies to Continue Marketing Infant Formula Under an Enforcement Discretion Letter Beyond November 14, 2022 Keller and Heckman LLP
Oct
3
2022
FDA Concludes Software Pre-Cert Pilot Program, Noting Federal Legislative Action is Needed Nelson Mullins
Sep
30
2022
OECD Accepting Comment on Draft Study Report on Applicability of the Key Event Based TG 442D for In Vitro Skin Sensitisation Testing of Nanomaterials Bergeson & Campbell, P.C.
Sep
30
2022
Medical Marijuana and the Construction Job Site Jackson Lewis P.C.
Sep
30
2022
USDA Focused on Accurate “Made in the USA” Beef Labeling Keller and Heckman LLP
Sep
30
2022
All Things Chemical® Podcast: The New Era of Smarter Food Safety — A Conversation with Karin Baron [PODCAST] Bergeson & Campbell, P.C.
Sep
29
2022
Wined and Fined: OFSI Imposes Financial Penalty on UK Company for Publicising Sanctioned Crimean Winery Greenberg Traurig, LLP
Sep
29
2022
QR Code and Text Messaging Alone Are Insufficient to Disclose Bioengineered Food Ingredients K&L Gates
Sep
29
2022
FDA Proposes Updated Definition for “Healthy” Claim Keller and Heckman LLP
Sep
29
2022
California Federal Court Substantially Upholds Bioengineered Food Disclosure But Remands QR Code and Text Message Disclosure Options to USDA for Further Rulemaking ArentFox Schiff LLP
Sep
29
2022
MintzRx — Medicaid Best Price Value Based Purchasing Rules Took Effect July 1, 2022 Mintz
Sep
29
2022
MintzRx — Pressure to Combat High Drug Prices Lands PBMs in the Hot Seat Mintz
Sep
29
2022
MintzRx — Drug Pricing Update: The Inflation Reduction Act Mintz
Sep
28
2022
4th Quarter 2022 Quick Hits for Plan Sponsors and Administrators Jackson Lewis P.C.
Sep
28
2022
Tension Over Copay Assistance and Maximizer Programs Continues Mintz
Sep
28
2022
MintzRx — Summer 2022 Enforcement Round-Up: Key Trends in Pharmacy Enforcement Actions Mintz
Sep
28
2022
MintzRx — Digital Health Update: Federal Government Shows Growing Enforcement Interest in Online Prescribing of Controlled Substances Mintz
Sep
28
2022
California Enacts Legal Protections for Cannabis Insurance Providers Wilson Elser Moskowitz Edelman & Dicker LLP
Sep
28
2022
Mere Puffery vs False Advertising: Recent Trends ArentFox Schiff LLP
Sep
28
2022
Developers Take Note: FDA Issues Clinical Decision Support Software Final Guidance Foley & Lardner LLP
Sep
28
2022
New Report Outlines FDA’s Strategy to Ensure the Safety of Imported Produce Keller and Heckman LLP
Sep
27
2022
DOJ Announces $900 Million Settlement Tied to Speaker Bureau Payments to Physicians Robinson & Cole LLP
Sep
27
2022
FDA Is Accepting EUA Requests for Monkeypox Tests, But Time is of the Essence Mintz
Sep
27
2022
Health Foods in China: New Rules Approving Functional Claims Keller and Heckman LLP
Sep
27
2022
Last Call: Deadline for Requesting Alabama Medical Cannabis Applications Looms Bradley Arant Boult Cummings LLP
Sep
27
2022
FDA Releases Food Safety Prevention Strategies Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins